(Q46789413)

25 December 2017

title

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer (English)

1 reference

25 December 2017

1 reference

6

M Schmidt

1 reference

25 December 2017

author name string

E Steiner

1

1 reference

25 December 2017

K Pollow

2

1 reference

25 December 2017

D Hasenclever

3

1 reference

25 December 2017

W Schormann

4

1 reference

25 December 2017

M Hermes

5

1 reference

25 December 2017

A Puhl

7

1 reference

25 December 2017

M Brulport

8

1 reference

25 December 2017

A Bauer

9

1 reference

25 December 2017

I B Petry

10

1 reference

25 December 2017

H Koelbl

11

1 reference

25 December 2017

J G Hengstler

12

1 reference

25 December 2017

language of work or name

English

0 references

publication date

28 January 2008

1 reference

25 December 2017

published in

Gynecologic Oncology

1 reference

25 December 2017

volume

108

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

569-576

1 reference

25 December 2017

Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

PAI-1 and cellular migration: dabbling in paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine ('Ecstasy') cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Tumor-associated proteolytic factors uPA and PAI-1 in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

ErbB-3 predicts survival in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.025

10.1016/J.YGYNO.2007.11.025

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017